Panel Discussion: Manufacturing Leaner & More Affordably to Accelerate Cell Therapy Development in Europe
- Identify key cost drivers in cell therapy manufacturing and discuss practical strategies to reduce them without compromising quality
- Debate approaches to efficient scale-out and scale-up that enable broader patient access while meeting regulatory and quality standards